-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
ince Capital
- Investments: 44
- Funds: 6
- Shanghai
-
Green transportation
Founded in 2019, INCE Capital is a venture capital firm with an investment focus on early to expansion stage companies that spearhead innovation in technology, Internet, and consumer industries. INCE Capital is committed to identifying innovators with great potential and empowering great enterprises in the future. INCE Capital currently manages more than US $1 billion in funds. Funders come from the world's top university funds, foundations, parent funds and family offices. INCE Capital focuses on venture capital from early stage to expansion stage, and concentrates on internet consumption and intelligent technology.
-
Oceanpine Capital
- Investments: 83
- Funds: 17
- Hong Kong
-
Energy storage
-
Lithium batteries
Oceanpine Capital is an institutional growth equity investment company that invests in innovative and disruptive growth companies in TMT and health care, which are the driving forces of the newly regulated future economy. Oceanpine Capital believes in long-term value investment and provides strategic financing resources and operational support for invested enterprises. The trading types of Oceanpine Capital are oriented to early growth and growth capital. Since its inception, Oceanpine Capital has invested in more than 70 companies in China and the U.S., mostly in the TMT and healthcare sectors, with more than a dozen of them making successful initial public offerings. The total investment amount has exceeded US $3 billion. Invested enterprises include Hina Battery, Svolt, BEST Semiconductor, Shansong, Mingmed, Giant Biogene, etc.
-
GL Ventures
- Investments: 425
- Funds: 38
- Zhuhai, Guangdong Province
-
Energy storage
-
Electric vehicles
-
New materials
Hillhouse Investment is a venture capital brand under the Hillhouse Group that focuses on investing in early-stage innovative enterprises. Since our establishment, Hillhouse Group has always focused on early-stage technological innovation investment in projects including Horizon Robotics, BeiGene, ZOOM, Blue Moon, and Ijovo.
-
Qiming VC
- Investments: 671
- Funds: 26
- Shanghai
-
Lithium batteries
-
Electric vehicles
-
Low-carbon consumer goods
-
Digital technology for carbon accounting and consulting
-
Circular economy
Qiming Venture Partners is a top-tier VC firm with outstanding reputation. With our exceptional investment performances, we have been widely recognized by investors from around the world. We have a reputation for being entrepreneur friendly.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi , Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Venus MedTech, Sanyou Medical, AmoyDx, Berry Genomics, SinocellTech, Yuanxin Technology, dMed-Clinipace, Belief BioMed, WeRide, Biren Technology and UBTech among many others.
-
CDH Fund
- Investments: 366
- Funds: 107
- Beijing
-
Photovoltaic
-
Lithium batteries
-
Grid/power transmission
-
Circular economy
Established in 2002, CDH Investments is one of the leading alternative investment fund managers focused on China today with over 1,726 yuan of assets under management, as of Sep, 2021. From its roots in private equity, CDH has expanded to become a diversified alternative asset management platform covering: Private Equity, Venture and Growth Capital, Securities Investment, Real Assets, Mezzanine Investment, and CDH Private Wealth Management. CDH Investments has successively invested in more than 300 enterprises in the fields of greater consumer products, medical and health care, enterprise services and hard technology innovation, of which 90 have been listed at home and abroad, and cultivated a number of industry leading brands.